Bay Street News, February 28th, 2025

Presented positive interim data through 52 weeks and beyond for 4D-150 in wet AMD from PRISM Phase 1/2 clinical trial […]

CHICAGO, Feb. 28, 2025 (GLOBE NEWSWIRE) — Mondelēz International (Nasdaq: MDLZ) today announced the appointment of Norberto Chaclin as Executive […]

Pivotal Phase 2b clinical trial (ELPIS II) evaluating Lomecel-B™ (laromestrocel) in Hypoplastic Left Heart Syndrome (HLHS), a rare pediatric disease and […]

Southfield, Michigan, Feb. 28, 2025 (GLOBE NEWSWIRE) — Credit Acceptance Corporation (Nasdaq: CACC) (referred to as the “Company”, “Credit Acceptance”, […]

CLAYTON, Mo., Feb. 28, 2025 (GLOBE NEWSWIRE) — FutureFuel Corp. (NYSE: FF) (“FutureFuel” or the “Company”), a manufacturer of custom […]

NEW YORK, Feb. 28, 2025 (GLOBE NEWSWIRE) — Silvercrest Asset Management Group Inc. (NASDAQ: SAMG) announced today it will host […]

BROOMFIELD, Colo., Feb. 28, 2025 (GLOBE NEWSWIRE) — Aclarion, Inc. (“Aclarion” or the “Company”) (NASDAQ: ACON) (NASDAQ: ACONW), a healthcare technology [...]

TORONTO, Feb. 28, 2025 (GLOBE NEWSWIRE) — Discovery Silver Corp. (TSX: DSV, OTCQX: DSVSF) (“Discovery” or the “Company”) is pleased […]

NEW YORK, Feb. 28, 2025 (GLOBE NEWSWIRE) — The Board of Directors at Verizon Communications Inc. (NYSE, Nasdaq: VZ) today […]

DIEPPE, New Brunswick, Feb. 28, 2025 (GLOBE NEWSWIRE) — Canadian Gold Resources Ltd. (“Canadian Gold” or the “Company”) (TSXV: CAN) […]